TY - JOUR
T1 - Differences in the effects of TRPV1 antagonists on energy metabolism in mice
AU - Hai, Jun
AU - Kawabata, Fuminori
AU - Kawabata, Yuko
AU - Liang, Ruojun
AU - Nishimura, Shotaro
AU - Tabata, Shoji
N1 - Funding Information:
This study was supported in part by grants to F. Kawabata from the Funds for the Development of Human Resources in Science and Technology, the Japan Science and Technology Agency, and the Kyushu University Interdisciplinary Programs in Education and Projects in Research Development (#26703). We thank Ms. Miho Morita for supporting the animal feeding.
Publisher Copyright:
© 2018, Biomedical Research Foundation. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Transient receptor potential vanilloid 1 (TRPV1) is a nociceptive cation channel that is activated by heat, protons and chemical ligands such as capsaicin. We investigated the roles of the capsaicin receptor, TRPV1, in controlling the energy metabolism of the whole body. It has been reported that the activation of TRPV1 by its agonists enhances energy metabolism. In this study, we used a respiratory gas analysis system to examine whether the inhibition of TRPV1 changes energy metabolism in mice. In addition, we examined the contributions of different modes of TRPV1 activation (heat, protons and capsaicin) to determine the influence of 3 different TRPV1 antagonists on energy metabolism. Here, we showed that intragastric administration of AMG517, a nonselective antagonist of TRPV1 (for heat, protons and capsaicin), enhanced energy metabolism as much as did intraperitoneal administration. On the other hand, intraperitoneal administration of AMG9810, a nonselective antagonist like AMG517, enhanced energy expenditure more than intragastric ad-ministration. However, the administration of JYL1421, a TRPV1 antagonist that very strongly inhibits TRPV1 activated by capsaicin, did not change energy metabolism. Taken together, these results suggest that the type of TRPV1 antagonists and the routes of its administration have different effects on energy metabolism in a normal body. Surprisingly, co-administration of JYL1421 and capsaicin significantly enhanced the energy metabolism more than administration of capsaicin alone. These results support the possibility that an unconventional mechanism is responsible for the increase in energy metabolism that occurs via TRPV1 inhibition.
AB - Transient receptor potential vanilloid 1 (TRPV1) is a nociceptive cation channel that is activated by heat, protons and chemical ligands such as capsaicin. We investigated the roles of the capsaicin receptor, TRPV1, in controlling the energy metabolism of the whole body. It has been reported that the activation of TRPV1 by its agonists enhances energy metabolism. In this study, we used a respiratory gas analysis system to examine whether the inhibition of TRPV1 changes energy metabolism in mice. In addition, we examined the contributions of different modes of TRPV1 activation (heat, protons and capsaicin) to determine the influence of 3 different TRPV1 antagonists on energy metabolism. Here, we showed that intragastric administration of AMG517, a nonselective antagonist of TRPV1 (for heat, protons and capsaicin), enhanced energy metabolism as much as did intraperitoneal administration. On the other hand, intraperitoneal administration of AMG9810, a nonselective antagonist like AMG517, enhanced energy expenditure more than intragastric ad-ministration. However, the administration of JYL1421, a TRPV1 antagonist that very strongly inhibits TRPV1 activated by capsaicin, did not change energy metabolism. Taken together, these results suggest that the type of TRPV1 antagonists and the routes of its administration have different effects on energy metabolism in a normal body. Surprisingly, co-administration of JYL1421 and capsaicin significantly enhanced the energy metabolism more than administration of capsaicin alone. These results support the possibility that an unconventional mechanism is responsible for the increase in energy metabolism that occurs via TRPV1 inhibition.
UR - http://www.scopus.com/inward/record.url?scp=85058560032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058560032&partnerID=8YFLogxK
U2 - 10.2220/biomedres.39.279
DO - 10.2220/biomedres.39.279
M3 - Article
C2 - 30531157
AN - SCOPUS:85058560032
SN - 0388-6107
VL - 39
SP - 279
EP - 286
JO - Biomedical Research
JF - Biomedical Research
IS - 6
ER -